Tepezza vs IV Steroids for Thyroid Eye Disease: Which Works?

When deciding between Tepezza (teprotumumab) and traditional intravenous (IV) steroids for active, moderate-to-severe thyroid eye disease, the choice depends on your specific symptoms, medical history, and treatment goals. Research shows that IV steroids are excellent for quickly reducing acute inflammation, redness, and eye pain, but they do little to reverse eye bulging. Tepezza, a newer targeted therapy, has shown significantly higher efficacy in actually reducing proptosis (eye bulging) and improving double vision.

⚠️ WARNING: When to Seek Urgent Care
This comparison is for active, moderate-to-severe thyroid eye disease. If you experience dim or reduced vision, colors looking washed out, loss of part of your visual field, severe eye pain, or an inability to close your eyelids completely, contact an eye specialist or seek emergency care immediately. These are signs of sight-threatening complications (like optic nerve compression or severe corneal damage) that require urgent medical intervention, often involving high doses of IV steroids and/or surgery, rather than a standard comparison of outpatient medications ^[1][2].

How They Work

IV steroids, such as intravenous methylprednisolone, are powerful anti-inflammatory medications. They work by broadly suppressing the immune system to calm the acute “active” inflammatory phase of thyroid eye disease ^[3].

Tepezza (teprotumumab) is a targeted biologic therapy. Instead of broadly suppressing the immune system, it blocks the insulin-like growth factor-1 receptor (IGF-1R), which is one of the key biological pathways involved in the disease ^[4]. By blocking this receptor, Tepezza helps reduce the swelling and fat expansion behind the eye.

Note: Both treatments are generally used during the “active” inflammatory phase of the disease. Once the disease becomes “inactive” (stable but with persistent structural changes like bulging or double vision), rehabilitative surgeries—such as orbital decompression or strabismus surgery—are often the standard next steps ^[2].

Comparing the Results

It is important to note that there is currently no completed randomized “head-to-head” clinical trial directly comparing Tepezza and IV steroids, though one is planned ^[5][6]. Much of the comparison relies on indirect estimates and studies where the drugs were compared to a placebo.

Eye Bulging (Proptosis)

• IV Steroids: Studies show that IV steroids have only a very modest, if any, effect on proptosis ^[7]. They are not reliably expected to pull the eye back into its normal position.
• Tepezza: In a major placebo-controlled clinical trial, 83% of patients on Tepezza achieved a clinically meaningful reduction in eye bulging (at least 2 millimeters), compared to only 10% on a placebo ^[4]. An indirect comparison analyzing separate trials estimated that Tepezza reduces proptosis by over 2 mm more than IV steroids, though this cross-trial estimate carries some uncertainty ^[6].

Double Vision (Diplopia)

• IV Steroids: Steroids can help some patients with double vision by reducing the muscle swelling that restricts eye movement, but the results are inconsistent ^[8].
• Tepezza: In placebo-controlled trials, Tepezza improved double vision by at least one grade in about 68% of patients who had double vision at baseline (compared to 29% on placebo) ^[4]. Keep in mind that a “one grade” improvement does not always mean the double vision completely disappears. While some analyses suggest Tepezza is better for motility than IV steroids, other reviews have found the difference to be less certain ^[6][8].

Inflammation and Pain

• IV Steroids: IV steroids are considered a cornerstone for rapidly controlling acute inflammatory activity, such as pain, redness, and swelling ^[7]. Guidelines often suggest IV steroids as a first-line choice if rapidly halting inflammation is the primary goal ^[9].
• Tepezza: Tepezza also significantly reduces inflammation and improves the clinical activity of the disease ^[4][10].

Differences in Side Effects and Administration

Because these medications work differently, they carry different risks and require different monitoring:

Tepezza

• Administration: Typically given as a series of 8 intravenous infusions, spaced exactly 3 weeks apart.
• Hearing Risks: Tepezza can cause hearing impairment, ringing in the ears (tinnitus), or a feeling of ear fullness. These issues can persist or occasionally become permanent. A baseline hearing test (audiogram) is recommended before starting, with ongoing monitoring ^[11].
• Blood Sugar: It can cause significant increases in blood sugar (hyperglycemia), even in people without a history of diabetes. Baseline and ongoing glucose monitoring is necessary ^[12].
• Bowel Issues: It may worsen pre-existing inflammatory bowel disease (IBD). Patients must report persistent diarrhea, abdominal pain, or rectal bleeding ^[13].
• Pregnancy: Tepezza can cause fetal harm. Effective contraception is required during treatment and for a specified period after the final dose ^[14].
• Other: Muscle spasms and infusion reactions can also occur ^[15].

IV Steroids

• Administration: Schedules and cumulative doses vary widely based on your doctor’s specific plan, ranging from short, urgent high-dose pulses to schedules spread over several months.
• General Side Effects: Common side effects include mood changes, weight gain, trouble sleeping, and an increased risk of infections ^[14][16].
• Blood Sugar and Blood Pressure: High doses can substantially raise blood sugar and blood pressure, requiring monitoring.
• Liver Health: High cumulative doses of IV methylprednisolone carry a risk of serious liver injury, so liver function tests are typically monitored.

Which is Right for You?

Medical guidelines vary, and the right choice depends on a highly individualized assessment ^[9]. Generally:

• If your main issue is prominent proptosis (eye bulging) or double vision, and you do not have contraindications, Tepezza is often discussed as a primary option due to its ability to reduce these structural symptoms.
• If your main issue is severe acute pain, redness, and swelling, or if cost, availability, or specific medical conditions (like hearing loss or IBD) make Tepezza unsuitable, IV steroids remain a highly effective standard treatment.

Your doctor will help you weigh these options based on your disease severity, blood tests, and lifestyle needs.